Skip to content
CNS Clinical Research

Hollywood, Florida

CNS clinical trials in Hollywood, FL

33 CNS studies are recruiting participants at sites in Hollywood as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Hollywood at a glance

  • 33 studies are recruiting at a site in Hollywood.
  • By phase: Phase 1 (2), Phase 2 (8), Phase 3 (21), Phase 4 (1), Observational (1).
  • By sponsor: industry (30), university, hospital or other (3).
  • By research area: Schizophrenia (15), Depression (11), Bipolar Disorder (4), Migraine (2), Multiple Sclerosis (1).
  • Most recent update to one of these records: November 13, 2026.

Depression studies recruiting in Hollywood

Basic details from each study's public record (the 30 most recently updated of 33). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    ACADIA Pharmaceuticals Inc.
    Study site
    The Medici Medical Research
    Registry record
    NCT07284667 · updated
  2. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Study site
    UM Sylvester Comprehensive Cancer Center at Hollywood
    Registry record
    NCT06748222 · updated
  3. A Study of Brenipatide in Adult Participants With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Encore Medical Research
    Registry record
    NCT07412756 · updated
  4. TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

    • Observational
    • From 18 months, up to 11 years
    • All sexes
    Sponsor
    State University of New York at Buffalo
    Study site
    Joe DiMaggio
    Registry record
    NCT07048574 · updated
  5. A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    NextPhase Research Florida - Hollywood
    Registry record
    NCT07775300 · updated
  6. Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT06966401 · updated
  7. A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    AbbVie
    Study site
    CenExel Hollywood FL /ID# 273101
    Registry record
    NCT06696755 · updated
  8. NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT06911112 · updated
  9. Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    LB Pharmaceuticals Inc.
    Study site
    Cenexel Hollywood Florida
    Registry record
    NCT07494305 · updated
  10. A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    AbbVie
    Study site
    CenExel Hollywood FL /ID# 278200
    Registry record
    NCT07276997 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Hollywood, FL on ClinicalTrials.gov.

Schizophrenia studies recruiting in Hollywood

  1. Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

    • Phase 3
    • Ages 18 to 55
    • All sexes
    Sponsor
    Minerva Neurosciences
    Study site
    Behavioral Clinical Research, Inc.
    Registry record
    NCT07565428 · updated
  2. A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

    • Phase 3
    • Ages 13 to 17
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    CenExel
    Registry record
    NCT07288567 · updated
  3. A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

    • Phase 3
    • Ages 5 to 17
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Research Centers of America - Hollywood - CenExel - PPDS
    Registry record
    NCT07424404 · updated
  4. Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Research Centers of America ( Hollywood )
    Registry record
    NCT07686263 · updated
  5. A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    MapLight Therapeutics
    Registry record
    NCT07459647 · updated
  6. A Study of Brenipatide in Adult Participants With Schizophrenia

    • Phase 2
    • Ages 18 to 55
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    NextPhase Research Florida - Hollywood
    Registry record
    NCT07410507 · updated
  7. NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT07105098 · updated
  8. NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT07114874 · updated
  9. Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT07227818 · updated
  10. A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

    • Phase 1
    • Ages 18 to 55
    • All sexes
    Sponsor
    Leal Therapeutics, Inc
    Study sites
    Behavioral Clinical Research, Inc. · CenExel Hollywood FL
    Registry record
    NCT07734493 · updated
  11. 52-week Open Label Safety-Tolerability Study

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    LB Pharmaceuticals Inc.
    Study site
    CenExel
    Registry record
    NCT07369154 · updated
  12. A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

    • Phase 1
    • Ages 18 to 55
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Research Centers of America ( Hollywood )
    Registry record
    NCT07061288 · updated
  13. NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT06963034 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Hollywood, FL on ClinicalTrials.gov.

Bipolar disorder studies recruiting in Hollywood

  1. A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Behavioral Clinical Research
    Registry record
    NCT06951711 · updated
  2. A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study sites
    Behavioral Clinical Research · Research Centers of America ( Hollywood )
    Registry record
    NCT06929273 · updated
  3. A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Research Centers of America ( Hollywood )
    Registry record
    NCT06951698 · updated
  4. An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT07288320 · updated

Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Hollywood, FL on ClinicalTrials.gov.

Multiple sclerosis (MS) studies recruiting in Hollywood

  1. Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

    • Phase 3
    • Ages 40 to 70
    • All sexes
    Sponsor
    Novartis Pharmaceuticals
    Study site
    Memorial Healthcare System
    Registry record
    NCT06846281 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Hollywood, FL on ClinicalTrials.gov.

Migraine studies recruiting in Hollywood

  1. Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

    • Phase 4
    • Ages 18 to 70
    • All sexes
    Sponsor
    Mayo Clinic
    Study site
    Memorial Healthcare
    Registry record
    NCT06972056 · updated
  2. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Study site
    Encore Medical Research /ID# 245682
    Registry record
    NCT05125302 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Hollywood, FL on ClinicalTrials.gov.

Ask about studies near Hollywood

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Florida

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call